1. Ivashkin V.T., Drapkina O. M., Maev I. V. i dr. Rasprostranennost' nealkogol'noi zhirovoi bolezni pecheni u patsientov ambulatorno-poliklinicheskoi praktiki v Rossiiskoi Federatsii: rezul'taty issledovaniya DIREG 2 // Rossiiskii zhurnal gastroenterologii, gepatologii i koloproktologii. - 2015. - № 6. - S. 31-41
2. Zobair M. Younossi, Deirdre Blissett, Robert Blissett, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe // Hepatology. - 2016. - Vol. 64. - № 5. - P. 1577-1586
3. Byrne C.D. NAFLD: A multisystem disease / C. D. Byrne, G. Targher // Journal of hepatology. - 2015. - vol. 62. - № 1. - P. 47-64
4. Loomba R. The global NAFLD epidemic / R. Loomba, A. J. Sanyal // Nat Rev Gastroenterol Hepatol. - 2013. - V.10. - P. 686-690
5. Cua I.H., George J. Non-alcoholic fatty liver disease // Hosp. Med. - 2005. - Vol. 66. - P. 106-111
6. Drapkina O.M. NAZhBP. Sovremennyi vzglyad na problemu / O. M. Drapkina, V. I. Smirin, V. T. Ivashkin // Lechashchii vrach. - 2010. - T. 5. - № 5. - S. 57-61
7. Drapkina O. M., Korneeva O. N. Kontinuum nealkogol'noi zhirovoi bolezni pecheni: ot steatoza pecheni do serdechno-sosudistogo riska // Ratsional'naya farmakoterapiya v kardiologii. - 2016. - T. 12. - № 4. - S. 424-429
8. Tilg H. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis / H. Tilg, A. R. Moschen // Hepatology. - 2010. - № 52. - R. 1836-46
9. Zvyagintseva T.D., Chernobai A. I., Gridneva S. V. Kishechnyi mikrobiom i nealkogol'naya zhirovaya bolezn' pecheni: patogeneticheskie svyazi i korrektsiya probiotikami // Zdorov'e Ukrainy. - 2016. - № 1(39). http://health-ua.com
10. Kravchuk Yu. A. Kliniko-morfologicheskie osobennosti steatogepatita alkogol'noi i metabolicheskoi etiologii. Diss. …dokt. med. nauk. - S.-Pb., 2016. - 286 s
11. Ardatskaya M. D., Bel'mer S. V., Dobritsa V. P., Zakharenko S. M., Lazebnik L. B., Minushkin O. N., Oreshko L. S., Sitkin S. I., Tkachenko E. I., Suvorov A. N., Khavkin A. I., Shenderov B. A. Disbioz (disbakterioz) kishechnika: sovremennoe sostoyanie problemy, kompleksnaya diagnostika i lechebnaya korrektsiya // Eksperimental'naya i klinicheskaya gastroenterologiya. - 2015. - vypusk 117. - № 5. - S. 13-50
12. Dzhulai G.S., Shchelochenkov S. V. Mikrobiota zheludochno-kishechnogo trakta v razvitii nealkogol'noi zhirovoi bolezni pecheni // Tverskoi meditsinskii zhurnal. - 2015. - № 5. - C. 41-52
13. Fedos'ina E.A., Zharkova M. S., Maevskaya M. V. Bakterial'naya kishechnaya mikroflora i zabolevaniya pecheni. // RZhGGK. - 2009. - T. 19. - № 6. - S. 73-81
14. Kostyukevich O. I. Bylova N. A., Simbirtseva A. S. Rol' kishechnoi mikrobioty v razvitii zabolevanii pecheni i zhelchevyvodyashchikh putei. // RMZh. - 2016. - № 11. - S. 713-720
15. Sajjad A., Mottershead M., Syn W. K. et al. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. // Aliment. Pharmacol. Ther. - 2005. - Vol. 22. - P. 291-299
16. Zhdanov K.V., Gusev D. A., Zakharenko S. M., Kurtukov M. V., Sukachev V. S. Disbioz kishechnika pri tsirroze pecheni // Eksperimental'naya i klinicheskaya gastroenterologiya. - 2011. - № 6. - S. 38-44
17. Babasheva G. G. Klinicheskoe znachenie endotoksina i lipopolisakharid-svyazyvayushchego belka u bol'nykh nealkogol'noi zhirovoi bolezn'yu pecheni. - Diss. …kand.med.nauk. - Stavropol', 2015. - 141 s
18. Klyaritskaya I.L., Semenikhina E. V. Rol' IL-8 i LBP v patogeneze sindroma izbytochnogo bakterial'nogo rosta u patsientov s nealkogol'nym steatogepatitom. // Krymskii terapevticheskii zhurnal. 2015. - № 2. - S. 54-60
19. DSS induced colitis increases portal LPS levels and enhances hepatic in-flammation and fibrogenesis in experimental NASH / E Gabele [et al.] // J Hepatol. - 2011. - N55. - R. 1391-1399
20. Elevated endotoxin levels in non-alcoholic fatty liver disease / A. L. Harte [et al.] // J Inflamm (Lond). - 2010. - Vol. 7. - R. 15
21. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children / A. Alisi, M. Manco, R. Devito, F. Piemonte, V. Nobili // J Pediatr Gastroenterol Nutr. - 2010. - Vol. 50. - R. 645-649
22. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake / S. Thuy [et al.] // J Nutr. - 2008. - Vol. 138. - R. 1452-1455
23. Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese / X. Liu [et al.] // Diabetologia. - 2014. - Vol. 57. - R. 1834-1841
24. Kucheryavyi Yu.A., Maevskaya E. A., Akhtaeva M. L., Krasnyakova E. A. Nealkogol'nyi steatogepatit i kishechnaya mikroflora: est' li potentsial prebioticheskikh preparatov v lechenii? // Meditsinskii sovet. Gastroenterologiya. - 2013. - № 3. - S. 46-51
25. Loginov V. A. Sindrom izbytochnogo bakterial'nogo rosta u bol'nykh so snizhennoi kislotoprodutsiruyushchei funktsiei zheludka (klinicheskoe znachenie, diagnostika i lechenie). - Diss. …kand.med.nauk. - M., 2015. - 126 s
26. Rusanova E.V., Niyazmatov A. G., Protas I. M. Rol' endotoksina v razvitii gnoino-septicheskikh zabolevanii i metody ego vyyavleniya v krovi // Al'manakh klinicheskoi meditsiny. - 2013. - № 29. - S. 70-73
27. Garbuzenko D. V., Mikurov A. A., Smirnov D. M. Bakterial'naya endotoksinemiya i risk razvitiya krovotechenii iz varikozno-rasshirennykh ven pishchevoda u bol'nykh tsirrozom pecheni // Klinicheskaya meditsina. - 2012. - № 7. - S. 48-51
28. Klinicheskie rekomendatsii po diagnostike i lecheniyu nealkogol'noi zhirovoi bolezni pecheni Rossiiskogo obshchestva po izucheniyu pecheni i Rossiiskoi gastroenterologicheskoi assotsiatsii / pod red. V. T. Ivashkina. - M., 2015. - 38 s
29. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-alcoholic Fatty Liver Disease // Journal of Hepatology. - 2016. - Vol. 64. - P. 1388-1402
30. Ledochowski M., Ledochowski E., Eisenmann A. Hydrogen Breath tests. - Verlag Ledochowski, Innsbruck, 2008. - P. 59
31. Alisi A., Ceccarelli S., Panera N., et al. Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis // Front Cell Infect. Microbiol. - 2012. - № 2. - P. 132